98 related articles for article (PubMed ID: 8394873)
1. Protective activity of lipid A analogue GLA-60 against murine cytomegalovirus infection in mice.
Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
J Med Virol; 1993 Jul; 40(3):222-7. PubMed ID: 8394873
[TBL] [Abstract][Full Text] [Related]
2. Protective activity of the lipid A analogue GLA-60 against murine cytomegalovirus infection in immunodeficient mice.
Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1399-403. PubMed ID: 8393081
[TBL] [Abstract][Full Text] [Related]
3. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.
Ikeda S; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1988; 9(1-2):37-46. PubMed ID: 3389769
[TBL] [Abstract][Full Text] [Related]
4. Immunopharmacological activities of chemically synthesized lipid A-subunit analogue GLA-27 combined with muramyl dipeptide via spacers of different carbon chain length.
Ikeda S; Kumazawa Y; Sai K; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Int J Immunopharmacol; 1988; 10(4):339-46. PubMed ID: 2459075
[TBL] [Abstract][Full Text] [Related]
5. Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.
Ikeda S; Matsuura M; Nakatsuka M; Homma JY; Kiso M; Hasegawa A; Nishimura C
J Clin Lab Immunol; 1990 Aug; 32(4):177-81. PubMed ID: 1966934
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
Eizuru Y; Nakagawa N; Hamasuna R; Minamishima Y
Nat Immun; 1992; 11(4):225-36. PubMed ID: 1384831
[TBL] [Abstract][Full Text] [Related]
7. Host defense mechanisms against murine cytomegalovirus infection induced by poly I:C in severe combined immune deficient (SCID) mice.
Ikeda S; Neyts J; De Clercq E
Proc Soc Exp Biol Med; 1994 Nov; 207(2):191-6. PubMed ID: 7524103
[TBL] [Abstract][Full Text] [Related]
8. Effect of stereospecificity of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-40 on the expression of immunopharmacological activities.
Kumazawa Y; Ikeda S; Takimoto H; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Eur J Immunol; 1987 May; 17(5):663-7. PubMed ID: 3495442
[TBL] [Abstract][Full Text] [Related]
9. Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activity.
Ikeda S; Nishimura C; Matsuura M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1990 Jun; 13(6):327-33. PubMed ID: 1699495
[TBL] [Abstract][Full Text] [Related]
10. Antiherpes activity of chemically synthesized lipid A-subunit analogue GLA-60 in immunosuppressed mice.
Ikeda S; Tominaga T; Nishimura C; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1989; 11(4):173-80. PubMed ID: 2545164
[TBL] [Abstract][Full Text] [Related]
11. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimicrobial activities of lipid A-subunit analogue GLA-27.
Nakatsuka M; Kumazawa Y; Ikeda S; Yamamoto A; Nishimura C; Homma JY; Kiso M; Hasegawa A
J Clin Lab Immunol; 1988 May; 26(1):43-7. PubMed ID: 3184160
[TBL] [Abstract][Full Text] [Related]
13. Inhibition in mice of experimental metastasis of B16 melanoma by the synthetic lipid A-subunit analogue GLA-60.
Nakatsuka M; Kumazawa Y; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1991; 13(1):11-9. PubMed ID: 2026470
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nonspecific resistance to microbial infections of synthetic lipid A-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone.
Nakatsuka M; Ikeda S; Kumazawa Y; Matsuura M; Nishimura C; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1990; 12(6):599-603. PubMed ID: 1703131
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives.
Nakatsuka M; Kumazawa Y; Matsuura M; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1989; 11(4):349-58. PubMed ID: 2777430
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant activities of synthetic lipid A subunit analogues and its conjugates with muramyl dipeptide derivatives.
Maeda H; Saiki I; Ishida H; Kiso M; Hasegawa A; Azuma I
Vaccine; 1989 Jun; 7(3):275-81. PubMed ID: 2675486
[TBL] [Abstract][Full Text] [Related]
17. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
18. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
[TBL] [Abstract][Full Text] [Related]
19. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
